PREDNISOLONE SODIUM PHOSPHATE | A076913 | PHARMACEUTICAL ASSOC INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Lowenstein Sandler on behalf of PAI Holdings, LLC dba P... FDA-2026-P-7013 Law firm Lowenstein Sandler on behalf of PAI Holdings LLC dba Pharmaceutical Associates Inc. and PAI Pharma filed this citizen petition requesting the FDA Commissioner investigate the stability and safety of Kesin Pharma's repackaged Prednisolone Sodium Phosphate Oral Solution 15 mg/5 mL unit-dose c | 505(q) | 2026-06-24 | Open | Lowenstein Sandler on behalf of PAI Holdings |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.